Newsletter | January 5, 2021

01.05.21 -- FDA Approves First Generic Of Drug Used To Treat Severe Hypoglycemia

Industry Insights
Create Brand Sustainability With Softgel Technology

Keeping an eye on some emerging trends that are shaping society and the pharmaceutical industry can help you meet diverse consumer preferences and potentially extend product lifecycles.

The Criticality Of API CDMO Selection: Insights From A Client

Small and emerging companies face challenges related to limited funding and resources, such as technical expertise and capacity, making it imperative they find a competent partner to support them.

Shortening The Timeline To First In Human (FIH) Clinical Dosage Form For Oral / Injectable Delivery

Lengthy early development timelines are common across new & emerging biotech companies for a multitude of reasons. Striking the right balance of speed, quality, risk, and investment allows you to shorten timelines and work with efficiency. Strategies adopted for a rapid development of a simple yet flexible format proves beneficial.

Expanding SPR Uses In Antibody Effector Function Determination

To minimize risk and to get “true” affinity in binding analysis, we've adopted the latest innovation in surface plasmon resonance technology to develop and qualify assays for mAbs and other therapeutic proteins.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.